Spotlight on BACE: The secretases as targets for treatment in Alzheimer disease

Journal of Clinical Investigation

Volumn 108, Issue 9, 2001, Pages 1243-1246

  Dingwall, C ^a  

^a Neurology CEDD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; BETA SECRETASE INHIBITOR; CHOLESTEROL; ENZYME INHIBITOR; GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; PRESENILIN 1; PRESENILIN 2; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; NEUROFIBRILLARY TANGLE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; SENILE PLAQUE;

EID: 0035197342     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI14402     Document Type: Review

References (49)

1. Neuropsychological features of Alzheimer's disease
2. Genes, models and Alzheimer's disease
3. Alzheimer's disease: Genes, proteins and therapy
4. Protofibrils, the unifying toxic mo]ecule of neurodegenerative disorders?
5. Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease
6. Presenilins: Genes for life and death
7. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
8. Familial Alzheimer's disease-linked presenin 1 variants elevate Aβ 1-42/1-40 ratio in vitro and in vivo
9. Peptidomimetic probes and molecular modeling suggest that Alzheimer's γ-secretase is an intramembrane-cleaving aspartyl protease
10. A firm base for drug development
11. Aβ-generating enzymes: Recent advances in βP- and γ-secretase research
12. Tau pathology in neurodegenerative diseases
13. Correlation between elevated levels of amyloid βpeptide in the brain and cognitive decline
14. Amyloid β generation: Reduced plaques and improved cognition
15. Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation
16. BACE is the major β-secretase for generation of Aβ peptides by neurons
17. BACE knockout mice are healthy despite lacking the primary β-secretase activity in brain: Implications for Alzheimer's disease therapeutics
18. Structure of the protease domain of Memapsin 2 (β secretase) complexed with inhibitor
19. Characterization of Alzheimer's β- secretase protein BACE
20. A furin-like convertase mediates the propepride cleavage of BACE, the Alzheimer's β-secretase
21. Processing of β-secretase by furin and other members of the proprotein convertase family
22. Post-translational processing of β-secretase (βamyloid-converting enzyme) and its ectodomain shedding
23. The pro domain of β-secretase does not confer strict zymogen-like properties but does assist proper folding of the protease domain
24. Targeting of membrane proteins to endosomes and lysosomes
25. A role for, acidic residues in di-leucine motif-based targeting to the endocytic pathway
26. Cleavage of Alzheimer's amyloid precursor protein by α-secretase occurs at the surface of neuronal cells
27. Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease
28. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
29. In search of γ- secretase
30. γ-secretase, evidence for multiple proteolytic activities and influence of membrane positioning ofsubstrate on generation of amyloid β peptides of varying length
31. Evidence that the 42 and 40-amino acid forms of amyloid β protein are generated from the β-amyloid precursor protein by different activities
32. The carboxytermini of β-amyloid peptides 1-40 and 1-42 are generated by distinct γ-secretase activities
33. Rank-order potencies for inhibition of the secretion of Aβ40 and Aβ42 suggest that both are generated by a single γ-secretase
34. The transmembrane aspartates in presenilin 1 and 2 -are obligatory for γ-secretase activiy and amyloid γ-protein generation
35. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity
36. Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1
37. Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1
38. Presenilin 1 is linked with γ-secretase activity, in the detergent solubilized stare
39. A substrate-based difluoro ketone selectively inhibits Alzheimer's γ-secretase activity
40. L-685,458, an aspartyl protease transition stare mimic, is a potent inhibitor of amyloid β-protein precursor γ-secretase activity
41. Fenchylamine sulfonamide inhibitors of amyloid β-peptide production by the γ-secretase proteolytic pathway: Potential for the treatment of Alzheimer's disease
42. Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain
43. Pharmacological knock-down of the presenilin 1 heterodimer by a novel γ-secretase inhibitor: Implications for presenilin biology
44. Biochemical characterization of the γ-secretase activity that produces β-amyloid peptides
45. Cholesterol modulation as an emerging strategy, for the treatment of Alzheimer's disease
46. Cholesterol modulates α-secretase cleavage of amyloid precursor protein
47. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methlyglutaryl coenzyme A reductase inhibitors
48. Lipid rafts and signal transduction
49. Compartmentalization of β-secrerase (Asp2) into low-buoyant density non-cavoclar lipid rafts